{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:09:20Z","timestamp":1790856560308,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R0AG057683"],"award-info":[{"award-number":["1R0AG057683"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG060393"],"award-info":[{"award-number":["R01AG060393"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG058439"],"award-info":[{"award-number":["F31AG058439"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013899","name":"M.S.I. Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016374","name":"Cures Within Reach","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.tips.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T08:14:47Z","timestamp":1563351287000},"page":"565-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Insights into Computational Drug Repurposing for Neurodegenerative Disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Manish D.","family":"Paranjpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Taubes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2019.06.003_bb0005","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jalz.2017.02.006","article-title":"Alzheimer\u2019s disease: the next frontier\u2014special report 2017","volume":"13","author":"Karlawish","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2019.06.003_bb0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.24897","article-title":"The burden of neurological disease in the United States: a summary report and call to action","volume":"81","author":"Gooch","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/scitranslmed.aal2074","article-title":"Neurodegeneration: from cellular concepts to clinical applications","volume":"8","author":"Katsnelson","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0025","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.tips.2019.06.003_bb0030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: a timely review","volume":"68","author":"Kolb","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/106002809402800612","article-title":"Tacrine: first drug approved for Alzheimer\u2019s disease","volume":"28","author":"Crismon","year":"1994","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tips.2019.06.003_bb0040","first-page":"1465","article-title":"Donepezil for dementia due to Alzheimer\u2019s disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.06.003_bb0045","first-page":"1465","article-title":"Galantamine for Alzheimer\u2019s disease and mild cognitive impairment","volume":"1","author":"Loy","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.06.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001191.pub3","article-title":"Rivastigmine for Alzheimer\u2019s disease","volume":"9","author":"Birks","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.06.003_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13311-014-0325-7","article-title":"Drug repositioning approaches for the discovery of new therapeutics for Alzheimer\u2019s disease","volume":"12","author":"Kim","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2019.06.003_bb0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer\u2019s disease","volume":"11","author":"Corbett","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2019.06.003_bb0065","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wsbm.1337","article-title":"In silico methods for drug repurposing and pharmacology","volume":"8","author":"Hodos","year":"2016","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/clpt.2009.293","article-title":"Deconstructing the drug development process: the new face of innovation","volume":"87","author":"Kaitin","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.06.003_bb0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drudis.2018.01.018","article-title":"A bibliometric review of drug repurposing","volume":"23","author":"Baker","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2019.06.003_bb0080","doi-asserted-by":"crossref","first-page":"311ra174","DOI":"10.1126\/scitranslmed.aaa9364","article-title":"Identification of type 2 diabetes subgroups through topological analysis of patient similarity","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of drug repositioning approaches and resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tips.2019.06.003_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0168-0102(01)00298-X","article-title":"Zonisamide has beneficial effects on Parkinson\u2019s disease patients","volume":"41","author":"Murata","year":"2001","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0095","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3389\/fphar.2017.00729","article-title":"Overcoming obstacles to drug repositioning in Japan","volume":"8","author":"Nishimura","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2019.06.003_bb0100","doi-asserted-by":"crossref","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","article-title":"Discovery and preclinical validation of drug indications using compendia of public gene expression data","volume":"3","author":"Sirota","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/bib\/bbv020","article-title":"A survey of current trends in computational drug repositioning","volume":"17","author":"Li","year":"2016","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.tips.2019.06.003_bb0110","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tips.2019.06.003_bb0115","doi-asserted-by":"crossref","first-page":"12711","DOI":"10.1073\/pnas.1501597112","article-title":"Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway","volume":"112","author":"Brum","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.06.003_bb0120","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1158\/0008-5472.CAN-13-3540","article-title":"Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling","volume":"74","author":"Van Noort","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0125","doi-asserted-by":"crossref","first-page":"96ra76","DOI":"10.1126\/scitranslmed.3002648","article-title":"Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease","volume":"3","author":"Dudley","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13040-018-0171-y","article-title":"Connecting genetics and gene expression data for target prioritisation and drug repositioning","volume":"11","author":"Ferrero","year":"2018","journal-title":"BioData Min."},{"key":"10.1016\/j.tips.2019.06.003_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jsbmb.2016.03.012","article-title":"Age, APOE and sex: triad of risk of Alzheimer\u2019s disease","volume":"160","author":"Riedel","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tips.2019.06.003_bb0145","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.neurobiolaging.2010.05.017","article-title":"Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline","volume":"33","author":"Beydoun","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2019.06.003_bb0150","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","article-title":"Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis","volume":"74","author":"Neu","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0155","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1212\/WNL.0000000000004494","article-title":"Sex differences in the prevalence of genetic mutations in FTD and ALS","volume":"89","author":"Curtis","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2019.06.003_bb0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ifacol.2019.02.002","article-title":"Modeling spatial and temporal patterns of APOE \u03b54 mediated glucose uptake in mild cognitive impairment and normal controls","volume":"51","author":"Chen","year":"2018","journal-title":"IFAC PapersOnLine"},{"key":"10.1016\/j.tips.2019.06.003_bb0165","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jalz.2017.10.005","article-title":"Exploring APOE genotype effects on Alzheimer\u2019s disease risk and amyloid \u03b2 burden in individuals with subjective cognitive decline: the FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results","volume":"14","author":"Moreno-Grau","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2019.06.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097608","article-title":"APOE \u03b54 is associated with disproportionate progressive hippocampal atrophy in AD","volume":"9","author":"Manning","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2019.06.003_bb0175","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1523\/JNEUROSCI.0305-12.2012","article-title":"Gender modulates the APOE 4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels","volume":"32","author":"Damoiseaux","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.06.003_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-16","article-title":"ApoE4 induces A\u03b242, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice","volume":"8","author":"Liraz","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2019.06.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101795","article-title":"The effect of ApoE \u03b54 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study","volume":"22","author":"Paranjpe","year":"2019","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.tips.2019.06.003_bb0190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","article-title":"Aggregation of vascular risk factors and risk of incident Alzheimer disease","volume":"65","author":"Luchsinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2019.06.003_bb0195","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.tips.2019.06.003_bb0200","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/WNL.0b013e318217e7a4","article-title":"Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease","volume":"76","author":"Li","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2019.06.003_bb0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2019.06.003_bb0210","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity nap: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2019.06.003_bb0215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4137\/BBI.S33124","article-title":"Cross-species transcriptomic comparison of in vitro and in vivo mammalian neural cells","volume":"9","author":"LoVerso","year":"2015","journal-title":"Bioinform. Biol. Insights"},{"key":"10.1016\/j.tips.2019.06.003_bb0220","first-page":"1","article-title":"In situ transcriptome characteristics are lost following culture adaptation of adult cardiac stem cells","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2019.06.003_bb0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/molehr\/gal018","article-title":"In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells","volume":"12","author":"Zaitseva","year":"2006","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.tips.2019.06.003_bb0230","first-page":"1","article-title":"Comprehensive transcriptomic analysis of cell lines as models of primary tumor samples across 22 tumor types","volume":"2018","author":"Yu","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2019.06.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168812","article-title":"Drug repositioning for Alzheimer\u2019s disease based on systematic \u201comics\u201d data mining","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2019.06.003_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28916-7","article-title":"An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets","volume":"8","author":"Ramos","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2019.06.003_bb0245","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0250","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0255","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0260","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0265","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/gim.2013.72","article-title":"The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future","volume":"15","author":"Gottesman","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0270","first-page":"1","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease","volume":"9","author":"Geifman","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.tips.2019.06.003_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2016.3783","article-title":"Sex and race differences in the association between statin use and the incidence of Alzheimer disease","volume":"74","author":"Zissimopoulos","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep08580","article-title":"Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records","volume":"5","author":"Paik","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2019.06.003_bb0285","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.procs.2017.11.177","article-title":"Pattern-based mining in electronic health records for complex clinical process analysis","volume":"119","author":"Metsker","year":"2017","journal-title":"Procedia Comput. Sci."},{"key":"10.1016\/j.tips.2019.06.003_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12911-017-0519-0","article-title":"Empirical advances with text mining of electronic health records","volume":"17","author":"Delespierre","year":"2017","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.tips.2019.06.003_bb0295","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/jamia\/ocv180","article-title":"Extracting information from the text of electronic medical records to improve case detection: a systematic review","volume":"23","author":"Ford","year":"2016","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.tips.2019.06.003_bb0300","first-page":"574","article-title":"Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud. Health Technol. Inform."},{"key":"10.1016\/j.tips.2019.06.003_bb0305","first-page":"485","article-title":"A secure protocol to distribute unlinkable health data","volume":"2005","author":"Malin","year":"2005","journal-title":"AMIA Annu. Symp. Proc."},{"key":"10.1016\/j.tips.2019.06.003_bb0310","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1067\/mem.2001.115214","article-title":"Probabilistic linkage of computerized ambulance and inpatient hospital discharge records: a potential tool for evaluation of emergency medical services","volume":"37","author":"Dean","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0315","first-page":"207","article-title":"Missing data imputation in the electronic health record using deeply learned autoencoders","volume":"22","author":"Beaulieu-Jones","year":"2017","journal-title":"Biocomput."},{"key":"10.1016\/j.tips.2019.06.003_bb0320","first-page":"1035","article-title":"Strategies for handling missing data in electronic health record derived data","volume":"1","author":"Wells","year":"2013","journal-title":"eGEMs (Wash DC)"},{"key":"10.1016\/j.tips.2019.06.003_bb0325","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/phar.1569","article-title":"Approach to addressing missing data for electronic medical records and pharmacy claims data research","volume":"35","author":"Bounthavong","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tips.2019.06.003_bb0330","series-title":"2015 IEEE International Conference on Data Science and Advanced Analytics","first-page":"1","article-title":"Improved risk predictions via sparse imputation of patient conditions in electronic medical records","author":"Saha","year":"2015"},{"key":"10.1016\/j.tips.2019.06.003_bb0335","first-page":"1227","article-title":"Regression with missing X\u2019s: a review","volume":"86","author":"Little","year":"1992","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.tips.2019.06.003_bb0340","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","article-title":"Missing value estimation methods for DNA microarrays","volume":"17","author":"Troyanskaya","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tips.2019.06.003_bb0345","first-page":"2287","article-title":"Spectral regularization algorithms for learning large incomplete matrices","volume":"11","author":"Mazumder","year":"2010","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0350","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12911-016-0318-z","article-title":"Nearest neighbor imputation algorithms: a critical evaluation","volume":"16","author":"Beretta","year":"2016","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.tips.2019.06.003_bb0355","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1002\/ana.21462","article-title":"Premotor Parkinson\u2019s disease: clinical features, detection, and prospects for treatment","volume":"64","author":"Siderowf","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson\u2019s disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0365","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.parkreldis.2007.06.007","article-title":"The premotor phase of Parkinson\u2019s disease","volume":"13","author":"Tolosa","year":"2007","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.tips.2019.06.003_bb0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2967\/jnumed.116.183152","article-title":"Metabolic imaging in Parkinson disease","volume":"58","author":"Meles","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0375","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","article-title":"Anxiety disorders and depressive disorders preceding Parkinson\u2019s disease: a case-control study","volume":"15","author":"Shiba","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tips.2019.06.003_bb0380","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1523\/JNEUROSCI.1402-13.2013","article-title":"Changes in brain function occur years before the onset of cognitive impairment","volume":"33","author":"Beason-Held","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.06.003_bb0385","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/brain\/awv404","article-title":"Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer\u2019s disease","volume":"139","author":"Rodriguez-Vieitez","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tips.2019.06.003_bb0390","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0395","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","article-title":"Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease","volume":"75","author":"Quiroz","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0400","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.06.003_bb0405","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-2010-091504","article-title":"Pre-clinical detection of Alzheimer\u2019s disease using FDG-PET, with or without amyloid imaging","volume":"20","author":"Mosconi","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.06.003_bb0410","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/brain\/119.6.2001","article-title":"Presymptomatic hippocampal atrophy in Alzheimer\u2019s disease. A longitudinal MRI study","volume":"119","author":"Fox","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.tips.2019.06.003_bb0415","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/mds.27128","article-title":"Glitazone use associated with reduced risk of Parkinson\u2019s disease","volume":"32","author":"Brakedal","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tips.2019.06.003_bb0420","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(15)00144-1","article-title":"Pioglitazone in early Parkinson\u2019s disease: a phase 2, multicentre, double-blind, randomised trial","volume":"14","author":"Simuni","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0425","first-page":"309","article-title":"Genetics of neurodegenerative diseases: an overview","volume":"145","author":"Pihlstr\u00f8m","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0430","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.trci.2017.01.001","article-title":"The effect of statins on rate of cognitive decline in mild cognitive impairment","volume":"3","author":"Smith","year":"2017","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.tips.2019.06.003_bb0435","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2019.06.003_bb0440","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2019.06.003_bb0445","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Collins","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2019.06.003_bb0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-801893-4.00001-8","article-title":"Genetics of Huntington disease","volume":"144","author":"Nance","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00298","article-title":"On the integration of in silico drug design methods for drug repurposing","volume":"8","author":"March-Vila","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2019.06.003_bb0460","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-62703-398-5_12","article-title":"Biophysical methods in drug discovery from small molecule to pharmaceutical","volume":"1008","author":"Holdgate","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tips.2019.06.003_bb0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/23808993.2018.1424535","article-title":"Drug repositioning: current approaches and their implications in the precision medicine era","volume":"3","author":"Talevi","year":"2018","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"10.1016\/j.tips.2019.06.003_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012214","article-title":"Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements","volume":"5","author":"de Franchi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2019.06.003_bb0475","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/ci3002974","article-title":"Chemoisosterism in the proteome","volume":"53","author":"Jalencas","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tips.2019.06.003_bb0480","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/minf.201300082","article-title":"Identification of similar binding sites to detect distant polypharmacology","volume":"32","author":"Jalencas","year":"2013","journal-title":"Mol. Inform."},{"key":"10.1016\/j.tips.2019.06.003_bb0485","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acs.jmedchem.6b00078","article-title":"Impact of binding site comparisons on medicinal chemistry and rational molecular design","volume":"59","author":"Ehrt","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2019.06.003_bb0490","first-page":"17","article-title":"NMDA receptors and Huntington\u2019s disease","volume":"2009","author":"Fernandes","year":"2009","journal-title":"Biol. NMDA Recept."},{"key":"10.1016\/j.tips.2019.06.003_bb0495","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1074\/jbc.M900141200","article-title":"The effects of amyloid precursor protein on postsynaptic composition and activity","volume":"284","author":"Hoe","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2019.06.003_bb0500","doi-asserted-by":"crossref","first-page":"33364","DOI":"10.1074\/jbc.M304240200","article-title":"Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors","volume":"278","author":"Song","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2019.06.003_bb0505","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nrd3556","article-title":"Convergent pathogenic pathways in Alzheimer\u2019s and Huntington\u2019s diseases: shared targets for drug development","volume":"10","author":"Ehrnhoefer","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2019.06.003_bb0510","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2174\/138620708785739952","article-title":"A ligand-based approach to mining the chemogenomic space of drugs","volume":"11","author":"Gregori-Puigjane","year":"2008","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.tips.2019.06.003_bb0515","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0520","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","article-title":"PubChem BioAssay: 2017 update","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0525","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1021\/jm201706b","article-title":"Exploring activity cliffs in medicinal chemistry","volume":"55","author":"Stumpfe","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2019.06.003_bb0530","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2019.06.003_bb0535","doi-asserted-by":"crossref","first-page":"98080","DOI":"10.1039\/C6RA21941A","article-title":"In silico drug repositioning for the treatment of Alzheimer\u2019s disease using molecular docking and gene expression data","volume":"6","author":"Xie","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.tips.2019.06.003_bb0540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0545","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/j.jalz.2017.06.112","article-title":"The effect of 6 months dosing on the rate of amyloid-related imaging abnormalities (ARIA) in the Marguerite Road Study","volume":"13","author":"Abi-Saab","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2019.06.003_bb0550","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.trci.2017.10.001","article-title":"A randomized, exploratory molecular imaging study targeting amyloid \u03b2 with a novel 8-OH quinoline in Alzheimer\u2019s disease: the PBT2-204 IMAGINE study","volume":"3","author":"Villemagne","year":"2017","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.tips.2019.06.003_bb0555","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","article-title":"A phase 3 trial of IV immunoglobulin for Alzheimer disease","volume":"88","author":"Relkin","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2019.06.003_bb0560","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-018-4932-2","article-title":"RNA-seq assistant: machine learning based methods to identify more transcriptional regulated genes","volume":"19","author":"Wang","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tips.2019.06.003_bb0570","first-page":"574723","article-title":"Deep learning of representations for transcriptomics-based phenotype prediction","volume":"2019","author":"Smith","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2019.06.003_bb0575","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/acs.molpharmaceut.7b00346","article-title":"DruGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico","volume":"14","author":"Kadurin","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tips.2019.06.003_bb0580","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0337-2","article-title":"Machine learning for molecular and materials science","volume":"559","author":"Butler","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.06.003_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep reinforcement learning for de novo drug design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2019.06.003_bb0590","first-page":"606","article-title":"Type 2 diabetes risk forecasting from EMR data using machine learning","volume":"2012","author":"Mani","year":"2012","journal-title":"AMIA Annu. Symp. Proc."},{"key":"10.1016\/j.tips.2019.06.003_bb0595","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CCM.0000000000002936","article-title":"An interpretable machine learning model for accurate prediction of sepsis in the ICU","volume":"46","author":"Nemati","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tips.2019.06.003_bb0600","first-page":"276","article-title":"Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: a case-study using Mount Sinai heart failure cohort","volume":"22","author":"Shameer","year":"2016","journal-title":"Pacific Symp. Biocomput."},{"key":"10.1016\/j.tips.2019.06.003_bb0605","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00401-017-1785-8","article-title":"Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis","volume":"135","author":"Bakkar","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2019.06.003_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-5-30","article-title":"Drug repositioning: a machine-learning approach through data integration","volume":"5","author":"Napolitano","year":"2013","journal-title":"J. Cheminform."},{"key":"10.1016\/j.tips.2019.06.003_bb0615","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/MNM.0000000000000890","article-title":"Artificial intelligence in the diagnosis of Parkinson\u2019s disease from ioflupane-123 single-photon emission computed tomography dopamine transporter scans using transfer learning","volume":"39","author":"Kim","year":"2018","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.tips.2019.06.003_bb0620","series-title":"2012 Proc. 35th Int. Conv. MIPRO","first-page":"958","article-title":"Ultrasound medical image recognition with artificial intelligence for Parkinson\u2019s disease classification","volume":"2012","author":"Blahuta","year":"2012"},{"key":"10.1016\/j.tips.2019.06.003_bb0625","article-title":"Exploration of machine learning techniques in predicting multiple sclerosis disease course","volume":"5","author":"Zhao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2019.06.003_bb0630","series-title":"Deep Learning and Data Labeling for Medical Applications. DLMIA 2016, LABELS 2016","first-page":"86","article-title":"Deep learning of brain lesion patterns for predicting future disease activity in patients with early symptoms of multiple sclerosis","volume":"Vol. 10008","author":"Yoo","year":"2016"},{"key":"10.1016\/j.tips.2019.06.003_bb0635","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroimage.2014.10.002","article-title":"Machine learning framework for early MRI-based Alzheimer\u2019s conversion prediction in MCI subjects","volume":"1","author":"Moradi","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.tips.2019.06.003_bb0640","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.neuroimage.2011.09.069","article-title":"Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer\u2019s disease","volume":"59","author":"Zhang","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.tips.2019.06.003_bb0645","doi-asserted-by":"crossref","first-page":"S1407","DOI":"10.1016\/j.jalz.2018.06.2928","article-title":"A deep learning prognostic model for early prediction of Alzheimer's disease based on hippocampal MRI data","volume":"14","author":"Li","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2019.06.003_bb0650","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/0008-5472.CAN-13-2971","article-title":"Cancer cell lines for drug discovery and development","volume":"74","author":"Wilding","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2019.06.003_bb0655","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2019.06.003_bb0660","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/nan.12440","article-title":"Review: neuropathology and behavioural features of transgenic murine models of Alzheimer\u2019s disease","volume":"43","author":"Ameen-Ali","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tips.2019.06.003_bb0665","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3349\/ymj.2017.58.3.479","article-title":"Metabolism-centric overview of the pathogenesis of Alzheimer\u2019s disease","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.tips.2019.06.003_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep05489","article-title":"Network dynamics of 3D engineered neuronal cultures: a new experimental model for in-vitro electrophysiology","volume":"4","author":"Frega","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2019.06.003_bb0675","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.stemcr.2017.10.026","article-title":"Systematic three-dimensional coculture rapidly recapitulates interactions between human neurons and astrocytes","volume":"9","author":"Krencik","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tips.2019.06.003_bb0680","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nbt.1993","article-title":"Evergreening: a common practice to protect new drugs","volume":"29","author":"Gaudry","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2019.06.003_bb0685","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/acn3.76","article-title":"Overcoming obstacles to repurposing for neurodegenerative disease","volume":"1","author":"Shineman","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tips.2019.06.003_bb0690","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/d41586-018-05722-9","article-title":"The search for better animal models of Alzheimer\u2019s disease","volume":"559","author":"King","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.06.003_bb0695","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/hmg\/ddh199","article-title":"Independent effects of APOE on cholesterol metabolism and brain A\u03b2 levels in an Alzheimer disease mouse model","volume":"13","author":"Mann","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2019.06.003_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0262-8","article-title":"The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease","volume":"13","author":"Cheng-Hathaway","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2019.06.003_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.57","article-title":"Preclinical models of Alzheimer\u2019s disease: relevance and translational validity","volume":"84","author":"Mullane","year":"2019","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.tips.2019.06.003_bb0710","doi-asserted-by":"crossref","first-page":"f4794","DOI":"10.1136\/bmj.f4794","article-title":"Sharing data from clinical trials: where we are and what lies ahead","volume":"347","author":"Lo","year":"2013","journal-title":"BMJ"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719301348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719301348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:51:08Z","timestamp":1777495868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614719301348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":142,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0165614719301348"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2019.06.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into Computational Drug Repurposing for Neurodegenerative Disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}